Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Improvement of sickle cell disease care mitigates the healthcare utilization induced by increased prevalence: Experience of a tertiary pediatric center

View Full Paper
Ask AI
Bookmark
Share

Authors

NFNatalie FournierVAValérie ArsenaultSFStéphanie Forté

Discussion

Loading...

Member takes

Overview

Retrospective analysis shows better management reduces hospitalizations and improves outpatient care among children with sickle cell disease.

Key Points

  • To analyze healthcare utilization trends for children with sickle cell disease at a tertiary care center over 15 years.
  • Retrospective review of healthcare utilization for pediatric patients with sickle cell disease from 2009 to 2024.
  • Evaluation of practice changes in the emergency and hematology departments.
  • Assessment of improvements in outpatient management and the introduction of a newborn screening program.
  • Number of pediatric patients with sickle cell disease increased from 221 to 499 over 15 years.
  • Outpatient visits rose from 1207 to 1769; ED visits increased from 192 to 526.
  • Hospitalizations remained stable while the average number of inpatient visits and transfusions per patient decreased.

Cite This Study

Fournier et al. (2025) studied this question.

synapsesocial.com/papers/693624d44fa91c937236cfbehttps://doi.org/10.1182/blood-2025-6532
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Implementation of a comprehensive sickle cell center leads to improved access to care and decreased acute care use2026
  2. 2Hemoglobin SC disease: Clinical analysis from the Georgia comprehensive sickle cell center at grady memorial hospital, Atlanta, Georgia.2025
  3. 3Inpatient and emergency healthcare utilization and payments for care of sickle cell disease: an analysis of all payers in Florida 2010-20192025
  4. 4Standardized Management of Sickle Cell Disease Patients and the Effects on Care Utilization and Costs2024 · 1 citations
  5. 5Evaluation of the Clinical and Haematological Response to Hydroxyurea Treatment in Patients with Sickle Cell Disease Attending the Haematology Clinic at Jitimai District Hospital2025